Margriet Oosterveld

Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study

Claudia A.M. Stege, Kazem Nasserinejad, Ellen van der Spek et al. · Journal of Clinical Oncology · 2021 · 63 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors

Margriet Oosterveld, Petra Muus, Stefan Suciu et al. · Leukemia · 2002 · 55 citations

Medicine, Oncology, Chemotherapy +14

The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)

Margriet Oosterveld, Stefan Suciu, G. Verhoef et al. · Leukemia · 2003 · 46 citations

Medicine, Hematology, Oncology +16

A case of tizanidine-induced hepatic injury

Elly M. de Graaf, Margriet Oosterveld, T Tjabbes et al. · Journal of Hepatology · 1996 · 26 citations

Pharmacy, Pharmacotherapy, Toxicology +12

The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups

Margriet Oosterveld, Shulamiet Wittebol, W.A.J.G. Lemmens et al. · British Journal of Haematology · 2003 · 20 citations · Full text

Medicine, Internal Medicine, Oncology +13